Oriola Corp.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: FI0009014351
EUR
1.11
-1.24 (-52.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

97.98 k

Shareholding (Dec 2011)

FII

0.10%

Held by 1 FIIs

DII

99.9%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

EUR 205 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.62%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

-22.99%

stock-summary
Price to Book

1.74

Revenue and Profits:
Net Sales:
494 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-52.79%
0%
-52.79%
6 Months
-52.79%
0%
-52.79%
1 Year
-52.79%
0%
-52.79%
2 Years
-58.73%
0%
-58.73%
3 Years
-65.6%
0%
-65.6%
4 Years
-73.85%
0%
-73.85%
5 Years
-75.15%
0%
-75.15%

Oriola Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.71%
EBIT Growth (5y)
-26.09%
EBIT to Interest (avg)
3.84
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
4.24
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
11.32%
ROE (avg)
4.12%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.24
EV to EBIT
77.88
EV to EBITDA
4.61
EV to Capital Employed
1.47
EV to Sales
0.05
PEG Ratio
NA
Dividend Yield
0.89%
ROCE (Latest)
1.89%
ROE (Latest)
-24.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2011stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10.47% vs 1.45% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -3.70% vs 69.66% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "493.90",
          "val2": "447.10",
          "chgp": "10.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.60",
          "val2": "6.00",
          "chgp": "-73.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.60",
          "chgp": "-18.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.60",
          "val2": "-5.40",
          "chgp": "-3.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.80%",
          "val2": "-6.00%",
          "chgp": "0.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.44% vs -2.94% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.90% vs -531.25% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,679.70",
          "val2": "1,493.80",
          "chgp": "12.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.30",
          "val2": "27.30",
          "chgp": "-14.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.70",
          "val2": "9.20",
          "chgp": "-5.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.30",
          "val2": "-21.70",
          "chgp": "89.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.10",
          "val2": "-20.70",
          "chgp": "2.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.90%",
          "val2": "9.00%",
          "chgp": "-0.21%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
493.90
447.10
10.47%
Operating Profit (PBDIT) excl Other Income
1.60
6.00
-73.33%
Interest
1.30
1.60
-18.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.60
-5.40
-3.70%
Operating Profit Margin (Excl OI)
-2.80%
-6.00%
0.32%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 10.47% vs 1.45% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -3.70% vs 69.66% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,679.70
1,493.80
12.44%
Operating Profit (PBDIT) excl Other Income
23.30
27.30
-14.65%
Interest
8.70
9.20
-5.43%
Exceptional Items
-2.30
-21.70
89.40%
Consolidate Net Profit
-20.10
-20.70
2.90%
Operating Profit Margin (Excl OI)
6.90%
9.00%
-0.21%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 12.44% vs -2.94% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.90% vs -531.25% in Dec 2023

stock-summaryCompany CV
About Oriola Corp. stock-summary
stock-summary
Oriola Corp.
Retailing
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Company Coordinates stock-summary
Company Details
Orionintie 5 , ESPOO None : 02200
stock-summary
Tel: 358 10 42999358 10 4292112
stock-summary
Registrar Details